Serum Free Light Chain Assay to Define Response and Progression in Immunoglobulin-Secretory Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Role of serum free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma
Am. J. Hematol 2022 Oct 05;[EPub Ahead of Print], P Tacchetti, S Rocchi, E Zamagni, S Barbato, I Rizzello, G De Cicco, L Pantani, K Mancuso, A Fusco, L Dozza, M Ursi, E Favero, C Terragna, N Testoni, M CavoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.